Longeveron Announces Topline Results of Phase 2b Study of Lomecel-B for Aging Frailty
-- Study meets one of the two analyses of primary efficacy endpoint: statistically significant dose-response in six-minute walk test (6MWT)...
News
Freeline Provides Executive Leadership Team Update; Company to Provide Corporate Update and Second Quarter 2021 Financial Results on Monday, August 16
Guidance across all programs remains unchanged for expected data and clinical development milestones in 2021LONDON, Aug. 13, 2021 (GLOBE NEWSWIRE)...
HEXO to transfer U.S. stock exchange listing to Nasdaq
OTTAWA, Aug. 13, 2021 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) announced today it...
CytoDyn Receives FDA Guidance for its HIV BLA Dose Justification Report
Company Believes All Issues Are Addressable and it Will Be Able to Continue BLA Resubmission CMC and Non-Clinical Sections Will...
Announcement on mandatory share repurchase
In relation to the previously announced JSC AB CITY mandatory repurchase of JSC Olainfarm shares, Financial and Capital Market Commission has published the...
Core One Labs’ Clinics Submit Application to Treat Patient With Psilocybin Psychedelic-Assisted Therapy
VANCOUVER, British Columbia, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN:...
NEXSTIM PLC HALF-YEARLY REPORT 1 JANUARY – 30 JUNE 2021 (UNAUDITED)
Company announcement, Inside Information, Helsinki, 13 August 2021 at 09:00 am (EEST) NEXSTIM PLC HALF-YEARLY REPORT 1 JANUARY – 30...
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – June 30, 2021
Message from the CEO As is well known, IBT is conducting a large phase III study ("The Connection Study"), the...
Pixium Vision announces geographical expansion of PRIMAvera European pivotal study with opening of first UK clinical site at Moorfields Eye Hospital
Pixium Vision announces geographical expansion of PRIMAvera European pivotal study with opening of first UK clinical site at Moorfields Eye...
Eliem Therapeutics Announces Closing of Initial Public Offering with Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
SEATTLE and CAMBRIDGE, United Kingdom, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (NASDAQ: ELYM), a clinical-stage biotechnology company...
SomaLogic’s Melody Harris Honored with C-Suite Award by the Denver Business Journal
NEW YORK and BOULDER, Colo., Aug. 12, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, a...
MediciNova Reports Second Quarter 2021 Financial Results and Business Update
Initiated preclinical animal studies for MN-166 as a treatment for chlorine gas-induced induced lung disease under partnership with BARDA Positive...
Pacific Health Care Organization, Inc. Reports its 2021 Second Quarter Results
Newport Beach, CA, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed...
Osmotica Pharmaceuticals plc to Present at H.C. Wainwright Ophthalmology Virtual Conference on August 17, 2021
BRIDGEWATER, N.J., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated...
Precipio Announces Q2-2021 and year-end Shareholder Update Call
Conference Call to be held on Monday, August 23rd, 2021 at 5:00 PM ESTNEW HAVEN, Conn., Aug. 12, 2021 (GLOBE...
William Guyer to join Corcept as Chief Development Officer
MENLO PARK, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the...
Mustang Bio Collaborates with Mayo Clinic on Novel CAR T Technology
The exclusively licensed platform has potential application for any tumor target Preclinical development to continue at Mayo Clinic Mustang to...
Cidara Provides Corporate Update and Reports Second Quarter 2021 Financial Results
SAN DIEGO, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed...
Checkmate Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Business Update
Clinical trial programs for vidutolimod (CMP-001) in melanoma and head and neck cancer indications ongoing Trial start-up activities to support...
Molecular Templates, Inc. Reports Second Quarter 2021 Financial Results
AUSTIN, Texas, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company...
